Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FGTI-2734 |
Trade Name | |
Synonyms | |
Drug Descriptions |
FGTI-2734 is a peptidomimetic inhibitor of RAS farnesylation and geranylgeranylation, which results in decreased membrane localization of RAS and downstream signaling, and potentially leads to decreased growth of RAS-mutant tumors (PMID: 31227505). |
DrugClasses | RAS Inhibitor (Pan) 12 |
CAS Registry Number | 1247018-19-4 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
FGTI-2734 | FGTI-2734 | 0 | 0 |
FGTI-2734 + Sotorasib | FGTI-2734 Sotorasib | 0 | 0 |